EXPERIENCE OF RESPIRATORY FLUOROHINOLONUM LAEVOFLOXACINE APPLICATION («FLORACID®») IN PATIENTS WITH NON-SEVERE COMMUNITY-ACQUIRED PNEUMONIA

Abstract

The dynamics of clinical and laboratory parameters in patients with community-acquired pneumonia were studied during the treatment with respiratory fluorohinolonum laevofloxacin «Floracid®». The high efficiency and safety of «Floracid®» were revealed during the research.

Keywords

• community acquired pneumonia
• fluoroquinolones
• treatment